Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TOXVÆRD SØLVSMEDJE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   7.3% 11.5% 6.3% 5.7% 5.5% 12.6% 20.9% 20.5%   Credit score (0-100)   35 22 37 39 40 18 1 1   Credit rating   BBB BB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   131 22.0 76.0 64.0 82.0 126 0.0 0.0   EBITDA   131 22.0 76.0 64.0 82.0 126 0.0 0.0   EBIT   131 22.0 76.0 64.0 82.0 126 0.0 0.0   Pre-tax profit (PTP)   131.0 22.0 72.0 58.0 79.0 126.4 0.0 0.0   Net earnings   102.0 17.0 56.0 45.0 62.0 98.1 0.0 0.0   Pre-tax profit without non-rec. items   131 22.0 72.0 58.0 79.0 126 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,141 1,050 996 927 875 855 233 233   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,200 1,072 1,022 1,025 925 964 233 233   Net Debt   -892 -806 -778 -756 -652 -705 -233 -233     See the entire balance sheet 1000.0 Volume  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   131 22.0 76.0 64.0 82.0 126 0.0 0.0   Gross profit growth   -30.7% -83.2% 245.5% -15.8% 28.1% 54.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,200 1,072 1,022 1,025 925 964 233 233   Balance sheet change%   -2.5% -10.7% -4.7% 0.3% -9.8% 4.3% -75.9% 0.0%   Added value   131.0 22.0 76.0 64.0 82.0 126.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.8% 1.9% 7.3% 6.3% 8.4% 13.4% 0.0% 0.0%   ROI %   11.5% 2.0% 7.4% 6.7% 9.1% 14.6% 0.0% 0.0%   ROE %   8.9% 1.6% 5.5% 4.7% 6.9% 11.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Equity ratio %   95.1% 97.9% 97.5% 90.4% 94.6% 88.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -680.9% -3,663.6% -1,023.7% -1,181.3% -795.1% -558.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Quick Ratio   15.5 38.4 30.8 8.1 14.0 6.4 0.0 0.0   Current Ratio   20.3 48.7 39.3 10.5 18.5 8.8 0.0 0.0   Cash and cash equivalent   892.0 806.0 778.0 756.0 652.0 704.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,141.0 1,050.0 996.0 927.0 875.0 854.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   131 22 76 64 82 126 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   131 22 76 64 82 126 0 0   EBIT / employee   131 22 76 64 82 126 0 0   Net earnings / employee   102 17 56 45 62 98 0 0